Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: RCMac who wrote (422)	4/26/1999 3:05:00 PM
From: aknahow	Respond to of 712

I think the Schering agreements make it less desirable to others as takeover target but since the split is 50/50 for the U.S. & Canada that might not prove to be insurmountable. Thanks for your post.

To: RCMac who wrote (422)	4/26/1999 3:15:00 PM
From: LLCF	Read Replies (1) \| Respond to of 712

<Let me join the celebration, with the thought that CORR is probably still very cheap in light of the potential of > Yes, please join in, especially since your valuable info helped me to decide to make this a major position for me. Thank you. <I'm hanging onto CORR, even when it's up 45% or so from the larger part of my position (at 8 5/8), since I think it has a lot of room to run from here; > I hear you, I've sold 1/3 here just so I can buy if it dips, and I've got my sights on a few others (NBIX for one), but I'm certainly in for the long haul and this is a major holding for me. DAK